Advertisement

Pharmaceutisch weekblad

, Volume 1, Issue 1, pp 1355–1367 | Cite as

Antipyretische analgetica voor jonge hinderen

  • H. L. M. Cox
  • E. W. Wuis
Overzichtsartikelen

Samenvatting

In Nederland is een groot aantal (combinatie)preparaten met antipyretische en analgetische werking voor toepassing bij jonge kinderen in gebruik. De voor- en nadelen van de in deze preparaten meest voorkomende geneesmiddelen worden besproken. Dit leidt tot de conclusie dat voor kinderen vanaf 3 maanden acetylsalicylzuur en paracetamol als antipyretische analgetica in aanmerking komen. Combinatie met coffeÏne en/of fenobarbital wordt niet zinvol geacht; combinatie met codeÏnefosfaat of een benzodiazepine zoals diazepam, of met promethazinehydrochloride komt slechts in bepaalde gevallen in aanmerking.

Besproken worden de factoren waarmee rekening moet worden gehouden bij het formuleren van optimale toedieningsvormen voor orale en rectale toediening van acetylsalicylzuur en paracetamol, alsmede de dosering van deze preparaten bij jonge kinderen. Op grond van de beschikbare gegevens worden als eerste keuze Carbasalaatcalcium-poeders FNA3 en Paracetamol-zetpillenFNA geadviseerd.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatuur

  1. Agurell, S., A. Berlin, H. Ferngren enB. Hellström (1975)Epilepsia 16, 277–283 [ref. inPharm. Weekblad (1967)111, 891].CrossRefPubMedGoogle Scholar
  2. Alder Hey (1977)Book of children's doses, Liverpool, 228–229.Google Scholar
  3. Anderson, K. W. (1963) In:Salicylate: an International Symposium (edited byA. St. J. Dixon, B. K. Martin, M. J. H. Smith enP. H. N. Wood); 217, Londen (ontleend aan GYöRY en STIEL 1968).Google Scholar
  4. Avery, G. S. (1976)Drug Treatment, Adiss Press, Sidney, 81.Google Scholar
  5. Balmus, K. J., D. K. F. Meyer enL. Meyler (1974)Ned. Tijdschr. Geneesk. 118, 377–384.Google Scholar
  6. Barletta, M. A. (1977)Drug Intell. Clin. Pharm. 11, 59.Google Scholar
  7. Bell, S. A., M. Berdigk enW. M. Holliday (1966)J. New Drugs 6, 284–293.PubMedGoogle Scholar
  8. Borg, K. O., G. Ekenved, R. Elofsson enJ. Sjögren (1975)Acta Pharm. Suec. 12, 491–498.PubMedGoogle Scholar
  9. Booy, R. H. (1972)Ned. Tijdschr. Tandheelk. 79, 69–75.Google Scholar
  10. Bowen, B. K., W. J. Krause enK. J. Ivey (1977)Brit. Med. J. II, 1052–1055.CrossRefGoogle Scholar
  11. Cacchillo, A. F., enW. H. Hassler (1954)J. Am. Pharm. Assoc. Sci. Ed. 43, 683–685.CrossRefGoogle Scholar
  12. Cid, E. (1974)Ann. Pharm. FranÇ. 32, 273–281.PubMedGoogle Scholar
  13. Connell, J. R. (1969)Rocky Mt. Med. J. oct., 57–61.Google Scholar
  14. Craig, J. O., I. C. Ferguson enJ. Syme (1966)Brit. Med. J. I, 757–761.CrossRefGoogle Scholar
  15. Davison, C., D. H. Hertig enR. Devine (1966)Clin. Pharmacol. Therap. 7, 239 (ontleend aan GYöRY en STIEL 1968).CrossRefGoogle Scholar
  16. Drug Therap. Bull. (1978)16, 97–99.Google Scholar
  17. Duggin, G. G. (1977)Australian J. Pharm. Sci. 6, 44 (ontleend aan: PRESCOTT 1979).Google Scholar
  18. Editorial (1975)Lancet II, 1189–1191.Google Scholar
  19. Feikema, W. J., F. J. M. Gabreëls enJ. Willemse (1973)Ned. Tijdschr. Geneesk. 117, 686–690.Google Scholar
  20. Feldman, S. (1975)Am. J. Hosp. Pharm. 32, 1173–1175.PubMedGoogle Scholar
  21. Gibaldi, M., enB. Grundhofer (1975)J. Pharm. Sci. 64, 1064–1066.CrossRefPubMedGoogle Scholar
  22. `Ginneken, C. A. M. Van (1978) persoonlijke mededeling.Google Scholar
  23. Goodman, L. S., enA. Gilman (1975)The Pharmacological Basis of Therapeutics, 5th Ed. MacMillan Publishing Co. Inc., New York, 325–350.Google Scholar
  24. Graatsma, B. H. (1979) Mondelinge mededeling.Google Scholar
  25. Györy, A. Z., enJ. N. Stiel (1968)Lancet II, 300–302.CrossRefGoogle Scholar
  26. Heimann, G., F. Neuwald enE. Gladtke (1978)Arzneim. Forsch. 28 (1), 1023.Google Scholar
  27. Heyst, A. N. P. Van, enS. A. Pikaar (1978)Vademecum Vergiftigingen, Elsevier, Amsterdam, 126, 146.Google Scholar
  28. Höbel, M., enM. Talebian (1960)Arzneimittel Forsch, 10, 653–656.Google Scholar
  29. Hunt, C. A., enP. R. Dunford (1977)J. Am. Pharm. Assoc. NS 17, 517.Google Scholar
  30. Ivey, K. J., G. R. Silvoso enW. J. Krause (1978)Brit. Med. J. I, 1586–1588.CrossRefGoogle Scholar
  31. Jun, H. W., C. W. Whitworth enL. A. Luzzi (1972)J. Pharm. Sci. 61, 1160–1162.CrossRefPubMedGoogle Scholar
  32. Karolyi, I., G. Kedvessy, G. Regdon enE. Regdon (1976)Pharmazie 31, 179–180.PubMedGoogle Scholar
  33. Keinänen, S., M. Hietula, S. Similä enK. Kouvalainen (1977)Eur. J. Clin. Pharmacol. 12, 77–80.CrossRefPubMedGoogle Scholar
  34. Lammers, W., F. A. Nelemans enP. Siderius (1975)Algemene Farmacotherapie, 3e druk, Stafleu, Leiden, 544–547.Google Scholar
  35. Leonards, J. R., enG. Levy (1967)Clin. Pharm. Therap. 8, 400–408;Ibidem (1969)10, 571–575.CrossRefPubMedGoogle Scholar
  36. Leonards, J. R., enG. Levy (1970)J. Pharm. Sci. 59, 1511.CrossRefPubMedGoogle Scholar
  37. Levy, G. (1965)Anesthesia Analgesia Current Res. 44, 837–841.Google Scholar
  38. Levy, G., enB. A. Hayes (1960)New Engl. J. Med. 262, 1053.CrossRefPubMedGoogle Scholar
  39. Levy, G., N. N. Khanna, D. M. Soda, O. Tsuzuki enL. Stern (1975)Pediatrics 55, 818–825.PubMedGoogle Scholar
  40. Levy, G., enT. Tsuchiya (1972)New Engl. J. Med. 287, 430–432.CrossRefPubMedGoogle Scholar
  41. Maron, J. J., enA. C. Ickes (1976)Curr. Therap. Res. 20, 45–53.Google Scholar
  42. Materia Medica Selecta (1978) 2e Ed., Elsevier, Amsterdam.Google Scholar
  43. Meredith, T. J., B. Newman enR. Goulding (1978)Brit. Med. J. II, 478–479.CrossRefGoogle Scholar
  44. Merkus, F. W. H. M. (1978)Het voorschnjven van geneesmiddelen, Bohn, Scheltema en Holkema, Utrecht.Google Scholar
  45. Mielke, C. H., D. Heiden, A. F. Britten, J. Ramos enP. Flavell (1976)J. Am. Med. Assoc. 235, 613–616.CrossRefGoogle Scholar
  46. Miller, R. P., J. R. Roberts enL. J. Fischer (1976)Clin. Pharmacol. Ther. 19, 284–294 [ref. inMed. Farm. Med. (1976)14, 3728–3729].CrossRefPubMedGoogle Scholar
  47. Mitchell, J. R., S. S. Thorgeirsson, W. Z. Potter, D. J. Jollow enH. Keiser (1977)Clin. Pharmacol. Ther. 16, 676–684.CrossRefGoogle Scholar
  48. Moertel, C. G., D. L. Ahmann, W. F. Taylor enN. Schwartau (1972)New Engl. J. Med. 286, 813–815.CrossRefPubMedGoogle Scholar
  49. Moës, A. (1974)J. Pharm. Bel. 29, 319–332;Ibidem (1976)31, 355–365.Google Scholar
  50. Moës, A. (1975)Labo-Pharma-Problèmes et Techniques no. 249, dec., 1191–1195.Google Scholar
  51. Moës, A., enF. Jaminet (1976)Pharm. Acta Helv. 51, 119–125.PubMedGoogle Scholar
  52. Moolenaar, F. (1979)Thesis, Biopharmaceutics of rectal administration of drugs in man, Krips Repro, Meppel.Google Scholar
  53. Moolenaar, F. (in druk).Google Scholar
  54. Moolenaar, F., L. Olthof enT. Huizinga (1979)Pharm. Weekblad, Sci. Ed. 1, 25–30.Google Scholar
  55. Morselli, P. L. (1976)Clin. Pharmacokin. 1, 81–98.CrossRefGoogle Scholar
  56. Neuwald, F., enF. Kunze (1964)Arzneimittel Forsch. 14, 1162.Google Scholar
  57. Nogen, A. G., enJ. E. Bremner (1978)J. Pediat. 92, 832–833.CrossRefPubMedGoogle Scholar
  58. Nowak, M. M., B. Brundhofer enM. Gibaldi (1974)Pediatrics 54, 23–26.PubMedGoogle Scholar
  59. Pagay, S. N., R. I. Poust enJ. L. Colaizzi (1974)J. Pharm. Sci. 63, 44.CrossRefPubMedGoogle Scholar
  60. Parkhouse, J. (1975)Drugs 10, 366–393.CrossRefPubMedGoogle Scholar
  61. Parkhouse, J., enP. Hallinon (1967)Brit. J. Anaesthesia 39, 146–154.CrossRefGoogle Scholar
  62. Parrott, E. L. (1971)J. Pharm. Sci. 60, 867–872;Ibidem (1975)64, 878–880.CrossRefPubMedGoogle Scholar
  63. Prescott, L. F., P. Roscoe, N. Wright enS. S. Brown (1971)Lancet I, 519–522.CrossRefGoogle Scholar
  64. Prescott, L. F. (1979) in:Side Effects of Drugs Annual 3, onder redactie vanM. N. G. Dukes, Excerpta Medica, Amsterdam en Oxford, 78–89.Google Scholar
  65. Problems of childhood (1976) British Medical Association, Londen, 62,Google Scholar
  66. Rachelefsky, G. S., A. Coulson, S. C. Siegel enE. R. Stiehm (1975)Pediatrics 56, 443.PubMedGoogle Scholar
  67. Robertson, W. O. (1978)Am. J. Diseases Children 132, 459 (ontleend aan: PRESCOTT 1979).Google Scholar
  68. Roller, L. (1977)Australian J. Hosp. Pharm. 7, 97–101.Google Scholar
  69. Rane, A., enJ. T. Wilson (1976)Clin. Pharmacokin. 1, 2–24.CrossRefGoogle Scholar
  70. Regdon, E., G. Regdon enI. Karolyi (1976)Pharmazie 31, 114–116.PubMedGoogle Scholar
  71. Samelius, V., enA. Aström (1958)Acta Pharmacol. Toxicol. 14, 240.CrossRefGoogle Scholar
  72. Samter, M., enR. F. Beers (1968)Ann. Internal Med: 68, 975.CrossRefGoogle Scholar
  73. Savet, J. F., I. Genoud, J. Pernod enM. Hermier (1969)Cah. Med. Lyon 45, 2705–2708.Google Scholar
  74. Schumacher, P. (1960)Arch. Kinderheilk. 163, 237–252.Google Scholar
  75. Seed, J. C. (1965)Clin. Pharmacol Therap. 6, 354–358.CrossRefGoogle Scholar
  76. Senior, N. (1974) in:Advances in Pharmaceutical Sciences. Vol. 4, onder redaetie vanH. S, Bean, A. H. Beckett enJ. Carless, Acad. Press, Londen, New York, San Francisco, 421.Google Scholar
  77. Shangraw, R. F., enW. Douglas Walking (1971)J. Pharm. Sci. 60, 600–602.CrossRefPubMedGoogle Scholar
  78. Shirkey, H. C. (1972)Pediatrie Therapy, 4th Ed., The C. V. Mosby Co., St. Louis, 31, 1107.Google Scholar
  79. Siu, H., enCh. Becker (1976)Hosp. Pharm. 11, 271–274.Google Scholar
  80. Steele, R. W., F. S. H. Young, J. W. Bass enH. C. Shirkey (1972)Am. J. Diseases Children 123, 204–206.CrossRefGoogle Scholar
  81. Stewart, J. H., enE. D. M. Gallery (1976)Austral. N.Z.J. Med. 6, 498–508 [ref. inMed. Farm. Med. (1977)15, 3992–3995].CrossRefGoogle Scholar
  82. Tarlin, L., Ph. Landrigan, R. Babineau enJ. L. Alpert (1972)Am. J. Diseases Children 124, 880–882.CrossRefGoogle Scholar
  83. Teunissen, P. C. (1977) persoonlijke mededeling.Google Scholar
  84. Tomovíc, D., enR. Hagmann (1977)Schweiz. Rundschau Med. (Praxis)68, 276–280.Google Scholar
  85. Tsuchiya, T., enG. Levy (1972)J. Pharm. Sci. 61, 8oo-8o1.Google Scholar
  86. Vandam, L. D. (1972)New Eng. J. Med. 286, 20–23.CrossRefPubMedGoogle Scholar
  87. Vest, M. (1962)Deut. Med. Woch. schr. 87, 2141–2147.CrossRefGoogle Scholar
  88. Vraag 62 (1977)Ned,. Tijdschr. Geneesk. 121, 1969–1970.Google Scholar
  89. Wilson, J. T. (1976)Southern Med. J. 69, 779–786.CrossRefPubMedGoogle Scholar
  90. Wilson, J. T., V. Kasantikul, R. Harbison enD. Martin (1978)Am. J. Diseases Children 132, 466–473.Google Scholar
  91. Windorfer Jr, A., W. Kuenzer enR. Urbanek (1974)Eur. J. Clin. Pharmacol. 7, 227–231.CrossRefPubMedGoogle Scholar
  92. Wood, B. S. B. (1972) in:The therapeutic choice in paediatrics, onder redaetie vanBurland, W. L., enB. M. Laurence, Churchill Livingstone, Edinburgh en Londen, 103–109.Google Scholar
  93. Wright, N., enL. F. Prescott (1973)Scot. Med. J. 18, 56–58.Google Scholar

Copyright information

© Bohn, Scheltema & Holkema 1979

Authors and Affiliations

  • H. L. M. Cox
    • 1
  • E. W. Wuis
    • 2
  1. 1.Laboratorium Nederlandse ApothekersNiederlande
  2. 2.Documentatie-en Informatiedienst KNMPNiederlande

Personalised recommendations